L. Munoz

Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment

S. Rives, A. Minguela, C. García-Calderón, 2021, Frontiers in Pediatrics.

Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study.

J. Krischer, P. Burger, M. Cohen, 1993, International journal of radiation oncology, biology, physics.

Intravenous immunoglobulin may lessen all forms of infection in patients receiving allogeneic bone marrow transplantation for acute lymphoblastic leukemia: a pediatric oncology group study.

J. Graham-Pole, R. Marcus, B. Camitta, 1988, Bone marrow transplantation.

A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors.

L. Frankel, N. Vapiwala, N. Winick, 2001, Medical and pediatric oncology.

A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group phase III randomized trial

N. Winick, S. Toledano, J. Pullen, 2001, Leukemia.

Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study.

J. Shuster, C. Civin, B. Camitta, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study.

B. Camitta, B. Leventhal, D. Strother, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.